Prenatal diagnosis of NADH:ubiquinone oxidoreductase deficiency.

Autor: Niers LE; Nijmegen Center for Mitochondrial Disorders, Department of Pediatrics, University Medical Center Nijmegen, Nijmegen, The Netherlands., Smeitink JA, Trijbels JM, Sengers RC, Janssen AJ, van den Heuvel LP
Jazyk: angličtina
Zdroj: Prenatal diagnosis [Prenat Diagn] 2001 Oct; Vol. 21 (10), pp. 871-80.
DOI: 10.1002/pd.162
Abstrakt: NADH:ubiquinone oxidoreductase (complex I of the mitochondrial respiratory chain) deficiency is a severe disorder with an often early fatal outcome. Prenatal diagnosis for complex I defects currently relies mainly on biochemical assays of complex I in fetal tissues such as chorionic villi (CV), and is only in a minority of cases possible by means of mutational analysis of nuclear-encoded genes of complex I. We report on our experience to date with prenatal diagnosis in pregnancies at risk for complex I deficiency. We measured complex I activity in native CV and/or cultured CV in 23 pregnancies in 15 families. In accordance with the results of the investigations in CV, 15 children were born clinically unaffected. Two prenatally diagnosed unaffected fetuses and two prenatally diagnosed affected fetuses were lost prematurely with spontaneous or provoked abortions, respectively. Two affected children were born (prenatally found to be affected). In two pregnancies a discrepancy between native and cultured cells was found. We conclude that prenatal diagnosis for complex I deficiency can be reliably performed. Pitfalls were encountered in using cultured CV as a result of maternal cell contamination (MCC). Future research on pathogenic nuclear mutations underlying complex I deficiency will extend the possibilities for prenatal diagnosis at the molecular level.
(Copyright 2001 John Wiley & Sons, Ltd.)
Databáze: MEDLINE
Externí odkaz: